Cargando…
Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice
OBJECTIVE: Secretoglobin (SCGB) 3A2 is a novel lung-enriched cytokine, previously shown to exhibit anti-inflammatory, growth factor, and anti-fibrotic activities. The latter activity was demonstrated using exogenously-administered recombinant SCGB3A2 in the bleomycin (BLM)-induced pulmonary fibrosis...
Autores principales: | Cai, Yan, Kimura, Shioko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641653/ https://www.ncbi.nlm.nih.gov/pubmed/26559674 http://dx.doi.org/10.1371/journal.pone.0142497 |
Ejemplares similares
-
Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice
por: Cai, Yan, et al.
Publicado: (2015) -
Secretoglobin Superfamily Protein SCGB3A2 Deficiency Potentiates Ovalbumin-Induced Allergic Pulmonary Inflammation
por: Kido, Taketomo, et al.
Publicado: (2014) -
Secretoglobin 3A2 eliminates human cancer cells through pyroptosis
por: Yokoyama, Shigetoshi, et al.
Publicado: (2021) -
Macrophage‐based delivery of anti‐fibrotic proteins alleviates bleomycin‐induced pulmonary fibrosis in mice
por: Liu, Huiying, et al.
Publicado: (2023) -
Regulation of LH/FSH expression by secretoglobin 3A2 in the mouse pituitary gland
por: Miyano, Yuki, et al.
Publicado: (2014)